A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAFV600E mutation-positive metastatic melanoma
Titel:
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAFV600E mutation-positive metastatic melanoma
Auteur:
Grippo, J. F. Zhang, W. Heinzmann, D. Yang, K. H. Wong, J. Joe, A. K. Munster, P. Sarapa, N. Daud, A.